XAB2 and colorectal carcinoma: The results showed that XAB2 knockdown increased the susceptibility of CRC cells to oxaliplatin-induced DNA damage, while XAB2 overexpression alleviated oxaliplatin-induced DNA damage in CRC cells (Fig. 4A-D).